HomeACADEMIA
ACADEMIA

Japan Esophageal Society to Recommend 5-FU + Cisplatin as 1st-Line Therapy for Esophageal Cancer in New Guidelines
(Jul.7.2016)

The Japan Esophageal Society (JES) plans to recommend the combination of 5-FU (fluorouracil) and cisplatin as first-line therapy for unresectable or recurrent esophageal cancer, the society revealed at its annual meeting on July 6. The JES plans to include this ...
(LOG IN FOR FULL STORY)

News Calendar